These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21868488)

  • 1. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
    Calabrese M; Federle L; Bernardi V; Rinaldi F; Favaretto A; Varagnolo MC; Perini P; Plebani M; Gallo P
    Mult Scler; 2012 Feb; 18(2):174-80. PubMed ID: 21868488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
    Stauch C; Reiber H; Rauchenzauner M; Strasak A; Pohl D; Hanefeld F; Gärtner J; Rostásy KM
    Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the distribution of cortical lesions in multiple sclerosis.
    Sormani M; Stromillo ML; Battaglini M; Signori A; De Stefano N
    Mult Scler; 2012 Feb; 18(2):229-31. PubMed ID: 21757533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis.
    Sharief MK; Thompson EJ
    Ann Neurol; 1991 Feb; 29(2):147-51. PubMed ID: 2012384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Calabrese M; Filippi M; Rovaris M; Bernardi V; Atzori M; Mattisi I; Favaretto A; Grossi P; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
    Mult Scler; 2009 Jan; 15(1):36-41. PubMed ID: 18755823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
    Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
    Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of intrathecal immunoglobulins in patients with multiple sclerosis.
    Di Pauli F; Gredler V; Kuenz B; Lutterotti A; Ehling R; Gneiss C; Schocke M; Deisenhammer F; Reindl M; Berger T
    J Neurol Sci; 2010 Jan; 288(1-2):147-50. PubMed ID: 19828154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
    Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
    Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative MRI and cerebrospinal fluid inflammatory mediators in Brazilian patients with relapsing-remitting multiple sclerosis before and after treatment with immunomodulators: a longitudinal study.
    Ruocco HH; Brandão CO; Farias AS; Oliveira C; Oliveira EC; Cendes F; Damasceno BP; Santos LM
    Neuroimmunomodulation; 2012; 19(5):277-82. PubMed ID: 22472803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
    Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
    Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis.
    Calabrese M; Battaglini M; Giorgio A; Atzori M; Bernardi V; Mattisi I; Gallo P; De Stefano N
    Neurology; 2010 Oct; 75(14):1234-40. PubMed ID: 20739644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
    Fialová L; Bartos A; Švarcová J; Zimova D; Kotoucova J
    J Neuroimmunol; 2013 Jun; 259(1-2):81-7. PubMed ID: 23632043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
    Calabrese M; De Stefano N; Atzori M; Bernardi V; Mattisi I; Barachino L; Morra A; Rinaldi L; Romualdi C; Perini P; Battistin L; Gallo P
    Arch Neurol; 2007 Oct; 64(10):1416-22. PubMed ID: 17923625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament light as a prognostic marker in multiple sclerosis.
    Salzer J; Svenningsson A; Sundström P
    Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study.
    Calabrese M; Filippi M; Rovaris M; Mattisi I; Bernardi V; Atzori M; Favaretto A; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
    Neuroimage; 2008 Oct; 42(4):1324-8. PubMed ID: 18652903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
    Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.